Skip to content

Source filing unavailable

Q1 2014 · —
Revenue$215.06M+9.4% vs Q1 2013−2.6% vs Q4 2013
Net Income$2.21MN/M vs Q1 2013−84.0% vs Q4 2013
EPS Diluted$0.07N/M vs Q1 2013−84.4% vs Q4 2013
Gross Profit$112,556,000−3.8%
Operating Income$8,738,000N/M
Operating Cash Flow$11,254,000+43.4%
Free Cash Flowderived-$81,000N/M
Margins · derived
Gross margin52.3%−7.2 pt vs Q1 2013
Operating margin4.1%+5.2 pt vs Q1 2013
Net margin1.0%+4.1 pt vs Q1 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2014Q1 2013Q1 2012Q1 2011
Revenue$215.06M$196.65M$196.19M$181.04M
Net Income$2.21M-$6.03M$6.69M$11.49M
EPS Diluted$0.07-$0.22$0.23$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR